Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

An Energy Minimization Method for MS Lesion Segmentation From T1-w and FLAIR Images.
Down-regulation of neuronal L1 cell adhesion molecule expression alleviates inflammatory neuronal injury.
The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury.
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis.
Intrathecal Dexmedetomidine for Anaesthetic Management of a Patient with Chronic Inflammatory Demyelinating Polyneuropathy.
Molecular diagnostics of neurodegenerative disorders.
Venous hypertensive myelopathy associated with cervical spondylosis.
Individual Differences in the Alignment of Structural and Functional Markers of the V5/MT Complex in Primates.
Introduction: Do we need multi-stakeholder colloquia in MS?
Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
Coding in Multiple Sclerosis and Other Demyelinating Diseases.
Defining and scoring response to IFN-β in multiple sclerosis.
Knockdown of Unconventional Myosin ID Expression Induced Morphological Change in Oligodendrocytes.
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody.
An unusual case of acute transverse myelitis caused by HSV-1 infection.
Diagnosis and Management of Multiple Sclerosis in Children.
A nationwide survey of pediatric acquired demyelinating syndromes in Japan.
Diffusion tensor imaging analysis of the brain in the canine model of Krabbe disease.
Neonatal Maternal Separation Impairs Prefrontal Cortical Myelination and Cognitive Functions in Rats Through Activation of Wnt Signaling.
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors?
Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.
Postreading Self-Assessment and CME Test.

Pages